Teacher Retirement System of Texas boosted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 392.2% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 170,146 shares of the company’s stock after buying an additional 135,581 shares during the period. Teacher Retirement System of Texas’ holdings in Zoetis were worth $10,849,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also bought and sold shares of the stock. Advisor Group Inc. raised its position in Zoetis by 42.2% during the third quarter. Advisor Group Inc. now owns 26,809 shares of the company’s stock valued at $1,710,000 after buying an additional 7,954 shares during the period. Los Angeles Capital Management & Equity Research Inc. increased its position in Zoetis by 6.7% in the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 484,892 shares of the company’s stock worth $30,917,000 after purchasing an additional 30,525 shares during the last quarter. Toronto Dominion Bank increased its position in Zoetis by 12.0% in the 3rd quarter. Toronto Dominion Bank now owns 186,173 shares of the company’s stock worth $11,869,000 after purchasing an additional 19,897 shares during the last quarter. Dorsey Wright & Associates acquired a new position in Zoetis in the 3rd quarter worth about $479,000. Finally, Jarislowsky Fraser Ltd increased its position in Zoetis by 13.1% in the 3rd quarter. Jarislowsky Fraser Ltd now owns 194,403 shares of the company’s stock worth $12,395,000 after purchasing an additional 22,500 shares during the last quarter. 92.44% of the stock is currently owned by hedge funds and other institutional investors.
Zoetis Inc. (NYSE ZTS) opened at $70.79 on Friday. The company has a debt-to-equity ratio of 2.45, a quick ratio of 1.95 and a current ratio of 2.80. The company has a market capitalization of $34,310.00, a PE ratio of 32.06, a PEG ratio of 2.04 and a beta of 1.02. Zoetis Inc. has a fifty-two week low of $48.55 and a fifty-two week high of $71.12.
The firm also recently announced a quarterly dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be paid a dividend of $0.105 per share. The ex-dividend date of this dividend is Wednesday, November 8th. This represents a $0.42 annualized dividend and a yield of 0.59%. Zoetis’s payout ratio is 22.11%.
Several research analysts have weighed in on the company. Zacks Investment Research raised Zoetis from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research report on Thursday, October 12th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $75.00 target price on shares of Zoetis in a research report on Wednesday, September 6th. BidaskClub lowered Zoetis from a “hold” rating to a “sell” rating in a research report on Friday, October 6th. Morgan Stanley upped their target price on Zoetis from $61.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Friday, November 3rd. Finally, The Goldman Sachs Group, Inc. reaffirmed a “neutral” rating and issued a $62.00 target price on shares of Zoetis in a research report on Monday, August 7th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $67.65.
TRADEMARK VIOLATION NOTICE: This article was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this article on another domain, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The correct version of this article can be read at https://sportsperspectives.com/2017/11/18/zoetis-inc-zts-position-lifted-by-teacher-retirement-system-of-texas.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis Inc. and related companies with MarketBeat.com's FREE daily email newsletter.